Form 4: USANA Health Sciences Executive Joshua Foukas Reports Stock Sale

Chief Legal Officer Joshua Foukas of USANA Health Sciences Inc. reports the sale of 5,732 shares of common stock at an average price of $32.539 per share.

Summary

• On March 12, 2025, Joshua Foukas, Chief Legal Officer of USANA Health Sciences Inc., sold 5,732 shares of common stock.
• The sale was executed at a weighted average price of $32.539 per share.
• The prices for individual transactions ranged from $32.50 to $32.60.
• Following the transaction, Foukas directly owns 0 shares of USANA Health Sciences Inc.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of a stock sale by an officer. It doesn't inherently indicate positive or negative sentiment about the company's future prospects.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities. The sale itself doesn't necessarily indicate a negative outlook for the company, as insiders may sell shares for various personal financial reasons.

Stakeholder Impact

• The sale of shares by an officer could potentially create uncertainty among shareholders, although the impact is likely to be minimal given the relatively small number of shares sold.

Key Dates